Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
AquaVenture Holdings Files Registration Statement for Proposed Initial Public Offering
-
Minera IRL Limited Responds to Reports of Unauthorized Press Release
-
Canaccord Genuity Raises Price Target on Maxwell Technologies (MXWL) Following Start-Stop System Impact Investigation
-
UPDATE: Canaccord Genuity Starts PayPal (PYPL) at Buy
-
UPDATE: Canaccord Genuity Upgrades Box, Inc. (BOX) to Buy
-
Canaccord Genuity Raises Price Target on Nike (NKE) to $119 Following 15c EPS Beat
-
Pre-Open Stock Movers 09/25: (BLPH) (SIEN) (NKE) Higher; (INAP) (FINL) (PIR) Lower (more...)
-
Till Capital Announces Normal Course Issuer Bid
-
Q2 Holdings (QTWO) Prices 3.8M Common Shares at $25.50
-
Q2 Holdings, Inc. Announces Pricing of Follow-on Offering of Common Stock
-
Canaccord Genuity Reiterates Buy on Vanda Pharmaceuticals (VNDA) Following New Fanapt Patent
-
Canaccord Genuity Raises Price Target on Radius Health (RDUS) Ahead of Human pK Studies
-
Canaccord Genuity Reiterates Buy on Interxion (INXN) After Spending Time with Management
-
Canadian Utilities Limited Announces Closing of $250 Million Preferred Share Issue
-
Q2 Holdings, Inc. Announces Launch of Proposed Follow-on Offering of Common Stock
-
Penumbra, Inc. Announces Closing of its Initial Public Offering
-
UPDATE: BioMed Realty (BMR) M&A Rumors Alter Value Debate, Says Canaccord Genuity; Rating Upgraded to Buy
-
Media Advisory: More Than 2,800 Participants & 40 Dogs Walk to Support SickKids
-
Canaccord Genuity Reiteates Buy on Intuitive Surgical (ISRG) Following Conversations with Management
-
Canaccord Genuity Cuts Price Target on Splunk (SPLK) to $75 Following Analyst Day
-
Canaccord Genuity Reiterates Buy on Trupanion (TRUP) Following Veterinarian Survey
-
Minera IRL Limited Announces Process of Removing Former Company Executive From Role With Peruvian Subsidiaries, Commencement of Criminal Proceedings and Corihuarmi Update
-
CCA Prices Offering of Senior Unsecured Notes
-
Veresen Announces Common Share Dividend for September 2015
-
Minera IRL Limited Announces Suspension of Trading on AIM
-
Canaccord Genuity Cuts Price Target on Rockwell Collins (COL) Following FY16 Guidance
-
Dates Announced for the 18th Annual ICR Conference
-
Survey Points to Further Apple (AAPL) iPhone Upside, Canaccord Genuity Says; PT Raised to $160
-
Spectrum and Elissa Announce that Elissa has Closed Its Private Placement Financing 85% Oversubscribed
-
Penumbra (PEN) IPO Opens Sharply Higher
-
Penumbra (PEN) IPO Prices at $30, Above Expected Range
-
Penumbra, Inc. Announces Pricing of Initial Public Offering
-
UPDATE: Canaccord Genuity Starts Allscripts (MDRX) at Buy
-
UPDATE: Canaccord Genuity Starts Envision Healthcare (EVHC) at Buy
-
UPDATE: Canaccord Genuity Starts Cerner (CERN) at Buy
-
UPDATE: Canaccord Genuity Starts Civitas Solutions (CIVI) at Buy
-
Notable Analyst Rating Changes 9/17: (NVDA) (TJX) (BK) Upgraded; (NRP) (HAS) (UBNT) Downgraded
-
Canaccord Genuity Raised Price target on Aerie Pharma (AERI) Following Rocket 2 Data
-
Canaccord Genuity Cuts Price Target on ARC Group Worldwide (ARCW) Following 6c EPS Miss
-
Canaccord Genuity Reiterates Buy on iRobot Corporation (IRBT) Following Announced Roomba 980
-
Canaccord Genuity Reiterates Buy on Under Armour (UA) Following Investor Day
-
Canaccord Genuity Starts MAXIMUS, Inc. (MMS) at Hold
-
Canaccord Genuity Starts Team Health (TMH) at Buy
-
Canaccord Genuity Starts MedAssets (MDAS) at Hold
-
Aquinox Announces Closing of $98.0 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Aquinox Announces Closing of $98.0 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Canaccord Genuity Reiterates Buy on Zynerba Pharma (ZYNE) Following GW Pharmaceutical's (GWPH) Positive CBD Data
-
Canaccord Genuity Reiterates Buy on ZELTIQ Aesthetics (ZLTQ) Following the Unveiling of CynoSure's SculpSure
-
Canaccord Genuity Reiterates Buy on American Assets Trust (AAT) as Founder & Chairman Ernest Rady takes over as CEO
-
Canaccord Genuity Cuts Price Target on Astronics Corp (ATRO) to $70 Ahead of Investor Day

